Moleculin Biotech Historical Earnings image   This MBRX historical earnings page last updated 11/11/2024
Moleculin Biotech Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202411/8/2024NA
Q2 20248/14/2024NA
Q1 20245/10/2024NA
Q4 20233/22/2024NA
Q3 202311/13/2023NA
Q2 20238/11/2023NA
Q1 20235/11/2023NA
Q4 20223/22/2023NA
Q3 202211/10/2022NA
Q2 20228/15/2022NA
Q1 20225/12/2022NA
Q4 20213/24/2022NA
Q3 202111/10/2021NA
Q2 20218/11/2021NA
Q1 20215/12/2021NA
Q4 20203/24/2021NA
Q3 202011/12/2020NA
Q2 20208/12/2020NA
Q1 20205/11/2020NA
Q4 20193/19/2020NA
Q3 201911/12/2019NA
Q2 20198/16/2019NA
Q1 20195/14/2019NA
Q4 20182/21/2019NA
Q3 201811/13/2018NA
Q2 20188/10/2018NA
Q1 20185/15/2018NA
Q4 20173/28/2018NA
Q3 201711/13/2017NA
Q2 20178/14/2017NA
Q1 20175/15/2017NA
Q4 20164/3/2017NA
Q3 201611/21/2016NA
Q2 20168/15/2016NA
Moleculin Biotech Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202411/8/2024-2.850
Q2 20248/14/2024-1.700
Q1 20245/10/2024-2.020
Q4 20233/22/2024-5.090
Q3 202311/13/2023-2.850
Q2 20238/11/2023-3.000
Q1 20235/11/2023-4.200
Q4 20223/22/2023-3.450
Q3 202211/10/2022-4.500
Q2 20228/15/2022-3.600
Q1 20225/12/2022-3.600
Q4 20213/24/2022-1.350
Q3 202111/10/2021-2.250
Q2 20218/11/2021-2.250
Q1 20215/12/2021-3.000
Q4 20203/24/2021-3.000
Q3 202011/12/2020-5.400
Q2 20208/12/2020-15.300
Q1 20205/11/2020-1.800
Q4 20193/19/2020-7.200
Q3 201911/12/2019-8.100
Q2 20198/16/2019-2.700
Q1 20195/14/2019-12.600
Q4 20182/21/2019-9.000
Q3 201811/13/2018-7.200
Q2 20188/10/2018-18.000
Q1 20185/15/2018-7.200
Q4 20173/28/2018-8.100
Q3 201711/13/2017-12.600
Q2 20178/14/2017-17.100
Q1 20175/15/2017-9.900
Q4 20164/3/2017-10.800
Q3 201611/21/2016-10.800
Q2 20168/15/2016-9.900
Quotes delayed 20 minutes

Email EnvelopeFree MBRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Moleculin Biotech (MBRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MCK Historical Earnings
MCRB Historical Earnings
MD Historical Earnings
MDGL Historical Earnings
MDT Historical Earnings
MDXG Historical Earnings
ME Historical Earnings
MEDP Historical Earnings
MEIP Historical Earnings
MGLN Historical Earnings
What was the record high MBRX historical earnings result?
In terms of earnings or revenue, what is the best MBRX historical earnings result that Moleculin Biotech has ever posted, and when?

✔️Accepted answer: Within our data set, the highest MBRX historical earnings result was set in Q4 2021, when Moleculin Biotech posted results of -1.350/share. The most successful revenue quarter within our data set was Q3 2024 when Moleculin Biotech reported revenue of NA.

What was the lowest Moleculin Biotech historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest MBRX has reported, and when?

✔️Accepted answer: Within our data set, the lowest MBRX historical earnings result was set in Q2 2018, when Moleculin Biotech posted results of -18.000/share. The smallest revenue quarter within our data set was Q3 2024 when Moleculin Biotech reported revenue of NA.

On this page we presented the MBRX historical earnings date information for Moleculin Biotech. Reviewing that Moleculin Biotech Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2021, when MBRX posted gaap of -1.350/share. Meanwhile the lowest MBRX historical earnings result was in Q2 2018, when MBRX posted gaap of -18.000/share. Moving to Moleculin Biotechs historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2024 when MBRX reported NA in revenue, while the smallest revenue quarter was Q3 2024 when MBRX reported NA in revenue.

For self directed investors doing their due diligence on MBRX or any other given stock, their research can benefit from looking into all of the Moleculin Biotech historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Moleculin Biotech historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for MBRX. Thanks for visiting, and the next time you need to research MBRX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding ZSML, Top Ten Hedge Funds Holding MLPX, Institutional Holders of IBKR.

 

Moleculin Biotech Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.